Profile
PXMD NVO VRTX REGN SGEN ALNY
Company Name PaxMedica, Inc. Common Stock Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $1.20M $555.15B $119.18B $111.79B $43.15B $35.01B
Employees 0.01K 69.26K 5.40K 13.93K 3.26K 2.10K
CEO Mr. Howard J. Weisman Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
PXMD NVO VRTX REGN SGEN ALNY
Quant Rating Score 2 3 2 4 3 2
Quant Rating Sell Neutral Sell Buy Neutral Sell
Trading
PXMD NVO VRTX REGN SGEN ALNY
Last Close $0.12 $126.95 $461.76 $1031.15 $228.74 $272.73
High 52 $4.5 $146.91 $505.78 $1201.76 $228.9 $287.01
Low 52 $0.08 $87.78 $343 $775.18 $211.74 $143.31
Price vs. 52 Week High -97.33 % -13.59 % -8.7 % -14.2 % -0.07 % -4.98 %
Price vs. 52 Week Low 50 % 44.62 % 34.62 % 33.02 % 8.03 % 90.31 %
Total Return
PXMD NVO VRTX REGN SGEN ALNY
1 Month Return -42.86 % -6.17 % -4.33 % -14.03 % 0 % 1.33 %
3 Month Return -45.45 % -11.64 % -2.58 % -3.56 % 0 % 11.24 %
6 Month Return -76.51 % -1.9 % 10.35 % 7.02 % 0 % 79.46 %
9 Month Return -86.38 % 23.65 % 13.27 % 21.38 % 0 % 42.64 %
YTD Return -84.15 % 22.72 % 13.49 % 17.4 % 0 % 42.48 %
1 Year Return -62.37 % 38.3 % 31.3 % 23.88 % 5.82 % 55.8 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PXMD NVO VRTX REGN SGEN ALNY
Dividend Yield Percentage (TTM) - 1.11 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.26 % -1.96 % 4.72 % -3.35 % 6.97 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.71 % - - - -
Growth
PXMD NVO VRTX REGN SGEN ALNY
Asset Growth 157.69 % 30.35 % 25.23 % 13.23 % -1.21 % 7.99 %
Gross Profit Growth - 32.32 % 9.25 % 6.49 % 22.93 % 74.75 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % 76.23 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 91.84 % 241.5 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 215.48 % 1865.57 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 494.04 % 1810.11 %
EBIT Growth -52.25 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Net Income Growth 3.71 % 50.71 % 8.96 % -8.87 % 9.51 % 61.08 %
Net Income 3 Yeari Growth Per Share 10.22 % 106.79 % 34.59 % 13.48 % -764.83 % 52.78 %
Net Income 5 Yeari Growth Per Share - 133.86 % 70.33 % 74.02 % -276.93 % 53.44 %
Net Income 10 Yeari Growth Per Share - 98.61 % 809.6 % 871.12 % -624.16 % -143.14 %
Operating Income Growth -52.25 % 37.11 % -12.94 % -14.6 % 10.13 % 64.06 %
Operating Cash Flow Growth (CFG) -77.37 % 38.06 % -14.35 % -8.39 % 9.07 % 119.24 %
Operating 3 Year CFG -91.05 % 118.29 % 9.63 % 76.95 % -148.34 % 115.59 %
Operating 5 Year CFG - 163.51 % 174.78 % 125.17 % -195.86 % 114.91 %
Operating 10 Year CFG - 150.92 % 6084.35 % 713.56 % -2622.09 % 174.76 %
EPS Growth 59 % 52.28 % 8.33 % -8.54 % 10.81 % 62.15 %
EPS Diluted Growth 59 % 52.37 % 8.35 % -9.03 % 10.81 % 62.15 %
Book Value Per Share 1224.7 % 29 % 25.58 % 15.03 % -9.83 % -35.86 %
Share Holder 3 Year Equity Growth Per Share 130.48 % 75.22 % 104.06 % 137.56 % 33.92 % -119.99 %
Share Holder 5 Year Equity Growth Per Share - 121.9 % 291.14 % 219.1 % 220.81 % -113.65 %
Share Holder 10 Year Equity Growth Per Share - 49.62 % 1030.79 % 1286.9 % 691.19 % -140.22 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -100 % 4.74 % 44.1 % 0.06 % -23.28 % 103.19 %
Free Cash Flow Growth -77.37 % 9.17 % -16.47 % -17.11 % 3.67 % 106.84 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
PXMD NVO VRTX REGN SGEN ALNY
Gross Profit Margin TTM - 84.53 % 86.43 % 86.08 % 75.4 % 87 %
Return on Assets TTM -2208.66 % 24.34 % -2.43 % 11.98 % -20.64 % -1.82 %
Return on Equity TTM -3167.06 % 87.5 % -2.91 % 16.3 % -28.06 % 47.92 %
Return on Capital Employed TTM 1180.72 % 61.51 % -2.36 % 12.08 % -29.5 % 3.47 %
Net Income Per EBT TTM 100 % 79.6 % -228.18 % 94.21 % 101.53 % 118.22 %
EBT Per Ebit TTM 114.39 % 101.17 % -54.74 % 116.55 % 93.47 % -60.11 %
EBIT Per Revenue TTM - 43.26 % -3.8 % 29.18 % -34.37 % 4.38 %
Cash Flow To Debt Ratio TTM - 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Receivables Turnover TTM - 3.88 6.23 2.36 3.64 7.58
Payables Turnover TTM - 1.34 4.27 3.34 2.52 4.12
Inventory Turnover TTM - 1.1 1.53 0.65 1.07 3.63
Fixed Asset Turnover TTM - 234.59 % 583 % 313.27 % 471.71 % 327.68 %
Asset Turnover TTM - 69.85 % 51.28 % 37.38 % 63.3 % 58.47 %
Operating Cash Flow Per Share TTM -1.22 25.87 -3.66 37.65 -2.87 2.94
Free Cash Flow Per Share TTM -1.22 14.81 -5.52 29.68 -3.73 2.52
Cash Per Share TTM 4.24 % 1405.52 % 2245.45 % 9080.94 % 657.5 % 2071.01 %
Operating Cash Flow Sales Ratio TTM - 44.7 % -9.14 % 30.18 % -23.48 % 15.88 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 57.25 % 151.04 % 78.82 % 129.82 % 85.66 %
Cash Flow Coverage Ratios TTM - 202.13 % -101.14 % 205.21 % -475.96 % 15.08 %
Price To Free Cash Flows Ratio TTM -0.13 56.24 -83.59 34.85 -61.54 109.81
Price To Operating Cash Flows Ratio TTM -0.09 32.82 -126.25 27.38 -79.67 92.85
Price Cash Flow Ratio TTM -0.09 32.82 -126.25 27.38 -79.67 92.85
Income Statement (TTM)
PXMD NVO VRTX REGN SGEN ALNY
Revenue $0B $232.26B $9.84B $13.12B $1.96B $1.83B
Gross Profit $0B $196.5B $8.58B $11.3B $1.55B $1.52B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 79.1% 83.02%
EBITDA $-0.02B $112.94B $3.93B $5.13B $-0.62B $-0.23B
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.44B
EPS Diluted -11 18.62 13.89 34.77 -3.3 -3.52
Balance Sheet (MRQ)
PXMD NVO VRTX REGN SGEN ALNY
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $2.34B
Total Liabilities $0B $207.93B $5.15B $7.11B $0.87B $4.05B
Total Equity $0B $106.56B $17.58B $25.97B $2.8B $-0.22B
Total Investments $0B $17.5B $3.45B $13.51B $1.42B $1.68B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $2.68B
Total Assets $0.01B $314.49B $22.73B $33.08B $3.67B $3.83B
Cash Flow Statement (TTM)
PXMD NVO VRTX REGN SGEN ALNY
Net Income $-0.02B $83.68B $3.62B $3.95B $-0.61B $-0.44B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.02B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $108.91B $3.54B $4.59B $-0.45B $0.1B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.9
ABCL AbCellera Biologics Inc. 2.555
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.95
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.42
ABSI Absci Corporation 4.095
ABUS Arbutus Biopharma Corporation 3.945
ABVC ABVC BioPharma, Inc. 0.6601
ABVX Abivax SA American Depositary Shares 11.6
ACAD ACADIA Pharmaceuticals Inc. 15.475
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.4
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9801
ACHV Achieve Life Sciences, Inc. 4.43
ACIU AC Immune SA 3.7
ACLX Arcellx, Inc. 84.15
ACRV Acrivon Therapeutics, Inc. Common Stock 7.28
ACST Acasti Pharma Inc. 3.0712
ETFs With Exposure to PXMD
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 181.709
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 136.86
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 136.87
VEMPX Vanguard Extended Market Index InstlPlus 0 337.76
Unlock